The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomic Biomarker-Global Market Insights and Sales Trends 2024
Synopsis
The global Genomic Biomarker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Biomarker in various end use industries. The expanding demands from the Hospitals and Diagnostic and research laboratories, are propelling Genomic Biomarker market. Protein Marker, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Marker segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Biomarker covered in this report include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac and Pfizer, etc.
The global Genomic Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Global Genomic Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Biomarker market, Segment by Type:
Protein Marker
Nucleic Acid Marker
Other
Global Genomic Biomarker market, by Application
Hospitals
Diagnostic and research laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Biomarker companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Genomic Biomarker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Biomarker in various end use industries. The expanding demands from the Hospitals and Diagnostic and research laboratories, are propelling Genomic Biomarker market. Protein Marker, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Marker segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Biomarker covered in this report include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac and Pfizer, etc.
The global Genomic Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Global Genomic Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Biomarker market, Segment by Type:
Protein Marker
Nucleic Acid Marker
Other
Global Genomic Biomarker market, by Application
Hospitals
Diagnostic and research laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Biomarker companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomic Biomarker
1.1 Genomic Biomarker Market Overview
1.1.1 Genomic Biomarker Product Scope
1.1.2 Genomic Biomarker Market Status and Outlook
1.2 Global Genomic Biomarker Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic Biomarker Market Size by Region (2018-2029)
1.4 Global Genomic Biomarker Historic Market Size by Region (2018-2023)
1.5 Global Genomic Biomarker Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic Biomarker Market Size (2018-2029)
1.6.1 North America Genomic Biomarker Market Size (2018-2029)
1.6.2 Europe Genomic Biomarker Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic Biomarker Market Size (2018-2029)
1.6.4 Latin America Genomic Biomarker Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic Biomarker Market Size (2018-2029)
2 Genomic Biomarker Market by Type
2.1 Introduction
2.1.1 Protein Marker
2.1.2 Nucleic Acid Marker
2.1.3 Other
2.2 Global Genomic Biomarker Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic Biomarker Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic Biomarker Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic Biomarker Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic Biomarker Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic Biomarker Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic Biomarker Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic Biomarker Revenue Breakdown by Type (2018-2029)
3 Genomic Biomarker Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic and research laboratories
3.2 Global Genomic Biomarker Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic Biomarker Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic Biomarker Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic Biomarker Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic Biomarker Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic Biomarker Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic Biomarker Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic Biomarker Revenue Breakdown by Application (2018-2029)
4 Genomic Biomarker Competition Analysis by Players
4.1 Global Genomic Biomarker Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Biomarker as of 2022)
4.3 Date of Key Players Enter into Genomic Biomarker Market
4.4 Global Top Players Genomic Biomarker Headquarters and Area Served
4.5 Key Players Genomic Biomarker Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic Biomarker Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad
5.1.1 Bio-Rad Profile
5.1.2 Bio-Rad Main Business
5.1.3 Bio-Rad Genomic Biomarker Products, Services and Solutions
5.1.4 Bio-Rad Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Recent Developments
5.2 Beckman Coulter
5.2.1 Beckman Coulter Profile
5.2.2 Beckman Coulter Main Business
5.2.3 Beckman Coulter Genomic Biomarker Products, Services and Solutions
5.2.4 Beckman Coulter Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.2.5 Beckman Coulter Recent Developments
5.3 Myriad Genetics
5.3.1 Myriad Genetics Profile
5.3.2 Myriad Genetics Main Business
5.3.3 Myriad Genetics Genomic Biomarker Products, Services and Solutions
5.3.4 Myriad Genetics Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Genomic Biomarker Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Genomic Biomarker Products, Services and Solutions
5.5.4 Roche Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 QIAGEN
5.6.1 QIAGEN Profile
5.6.2 QIAGEN Main Business
5.6.3 QIAGEN Genomic Biomarker Products, Services and Solutions
5.6.4 QIAGEN Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.6.5 QIAGEN Recent Developments
5.7 Epigenomics
5.7.1 Epigenomics Profile
5.7.2 Epigenomics Main Business
5.7.3 Epigenomics Genomic Biomarker Products, Services and Solutions
5.7.4 Epigenomics Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.7.5 Epigenomics Recent Developments
5.8 Almac
5.8.1 Almac Profile
5.8.2 Almac Main Business
5.8.3 Almac Genomic Biomarker Products, Services and Solutions
5.8.4 Almac Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.8.5 Almac Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Genomic Biomarker Products, Services and Solutions
5.9.4 Pfizer Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 Human Longevity
5.10.1 Human Longevity Profile
5.10.2 Human Longevity Main Business
5.10.3 Human Longevity Genomic Biomarker Products, Services and Solutions
5.10.4 Human Longevity Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.10.5 Human Longevity Recent Developments
5.11 ValiRx
5.11.1 ValiRx Profile
5.11.2 ValiRx Main Business
5.11.3 ValiRx Genomic Biomarker Products, Services and Solutions
5.11.4 ValiRx Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.11.5 ValiRx Recent Developments
5.12 Personalis
5.12.1 Personalis Profile
5.12.2 Personalis Main Business
5.12.3 Personalis Genomic Biomarker Products, Services and Solutions
5.12.4 Personalis Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.12.5 Personalis Recent Developments
5.13 Eagle Genomics
5.13.1 Eagle Genomics Profile
5.13.2 Eagle Genomics Main Business
5.13.3 Eagle Genomics Genomic Biomarker Products, Services and Solutions
5.13.4 Eagle Genomics Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.13.5 Eagle Genomics Recent Developments
5.14 Empire Genomics
5.14.1 Empire Genomics Profile
5.14.2 Empire Genomics Main Business
5.14.3 Empire Genomics Genomic Biomarker Products, Services and Solutions
5.14.4 Empire Genomics Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.14.5 Empire Genomics Recent Developments
5.15 Agilent
5.15.1 Agilent Profile
5.15.2 Agilent Main Business
5.15.3 Agilent Genomic Biomarker Products, Services and Solutions
5.15.4 Agilent Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.15.5 Agilent Recent Developments
5.16 Illumina
5.16.1 Illumina Profile
5.16.2 Illumina Main Business
5.16.3 Illumina Genomic Biomarker Products, Services and Solutions
5.16.4 Illumina Genomic Biomarker Revenue (US$ Million) & (2018-2023)
5.16.5 Illumina Recent Developments
6 North America
6.1 North America Genomic Biomarker Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomic Biomarker Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarker Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic Biomarker Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarker Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic Biomarker Market Dynamics
11.1 Genomic Biomarker Industry Trends
11.2 Genomic Biomarker Market Drivers
11.3 Genomic Biomarker Market Challenges
11.4 Genomic Biomarker Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
